DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Catherine Schuster-Bruce"


7 mentions found


☆ Here are the 15 hottest startups in the psychedelics industry, according to top investors
  + stars: | 2023-03-27 | by ( Yeji Jesse Lee | Catherine Schuster-Bruce | ) www.businessinsider.com   time to read: +1 min
Despite a downturn, psychedelic VCs have invested hundreds of millions of dollars in recent years. Insider asked the leading VCs in psychedelics to name the hottest startups in the field. It's been a tough market for the psychedelics industry. Insider identified the top 14 venture-capital investors operating in the psychedelics industry based on how much money they had poured into the space. Here are the hottest startups in the psychedelics industry according to investors, listed in alphabetical order:
☆ Meet the top 14 VCs who've bet the most cash on turning psychedelics into medical treatments
  + stars: | 2023-03-16 | by ( Yeji Jesse Lee | Catherine Schuster-Bruce | ) www.businessinsider.com   time to read: +1 min
The firms on this list have invested about $347 million in psychedelics startups. Despite a downturn in venture funding, investors focused on psychedelics startups are continuing to write checks to back companies focused on developing compounds like MDMA and psilocybin, the psychoactive compound found in magic mushrooms. We narrowed our list to 14 firms by including only funds that invested at least $5 million into psychedelics companies and had portfolios made up of at least 30% psychedelics startups. Investors focused on earlier-stage startups, with most of the funds going to Series A rounds. Here are the top investors in the psychedelics industry, listed by how much capital they've deployed:
☆ The 22 clinical trials that could make or break the future of the $100 billion psychedelics industry
  + stars: | 2023-02-23 | by ( Catherine Schuster-Bruce | Yeji Jesse Lee | Shayanne Gal | ) www.businessinsider.com   time to read: +2 min
Hundreds of experiments are in progress worldwide, examining psychedelics' potential as medicines. Insider identified 22 key trials that could make or break the psychedelics industry's future. If they succeed, these trials could pave the way for psychedelics to be used as medical treatments. Hundreds of clinical trials are underway worldwide, examining the potential of psychedelics as treatments for health conditions, including post-traumatic stress disorder, severe depression, and anorexia. The total market for psychedelics-related medicines could eventually reach $100 billion, according to a 2020 report from Tania Gonsalves at Canaccord Genuity.
☆ A man thought his hip hurt because he'd ran a marathon. He was diagnosed with prostate cancer that had spread to his bones.
  + stars: | 2023-01-27 | by ( Catherine Schuster-Bruce | ) www.businessinsider.com   time to read: +3 min
A man who went to a chiropractor with hip pain was diagnosed with advanced prostate cancer. Scans found that he had prostate cancer that had spread to his bones, liver, and lungs. Further tests confirmed that he had the most common type of prostate cancer, called an adenocarcinoma. According to the report, the man died from a lung infection seven months after being diagnosed with prostate cancer. CDC data suggests that about 96% of men who are diagnosed with prostate cancer are alive five years later.
☆ A 24-year-old says she 'ignored' her bloating and stomach pain until it got so bad she went to the ER. Doctors diagnosed her with ovarian cancer.
  + stars: | 2023-01-27 | by ( Catherine Schuster-Bruce | ) www.businessinsider.com   time to read: +4 min
A woman, 24, found out she had ovarian cancer after her stomach pain got so bad she went to the ER. Etheridge told SWNS that she "ignored" her pain for months because she didn't know cancer could cause it. Generally, people are diagnosed with ovarian cancer after menopause and it's rare in people younger than 40 to develop the disease, according to the American Cancer Society. "I don't think young women know the symptoms of ovarian cancer," she said. Chemotherapy was 'brutal'Treatment of ovarian cancer depends on the type of cancer and how far it has spread, but includes chemotherapy, hormone therapy, and surgery.
☆ We're tracking the most important experiments that could turn psychedelics like LSD and ecstasy into approved medicines
  + stars: | 2022-06-01 | by ( Catherine Schuster-Bruce | Yeji Jesse Lee | Shayanne Gal | ) www.businessinsider.com   time to read: +2 min
Hundreds of clinical trials are testing psychedelic drugs like LSD and MDMA as medical treatments. Insider is tracking the key experiments that will show whether or not psychedelics actually work. Our psychedelics clinical trial tracker is available exclusively to Insider subscribers. To find out whether psychedelics can really work as treatments for PTSD, depression, and other ailments, researchers are testing them in clinical trials. Click here to see our interactive tracker monitoring these clinical trials.
☆ The 19 clinical trials that could make or break the future of the $100 billion psychedelics industry
  + stars: | 2022-06-01 | by ( Catherine Schuster-Bruce | Yeji Jesse Lee | Shayanne Gal | ) www.businessinsider.com   time to read: +3 min
About 100 experiments are in progress worldwide, examining psychedelics' potential as medicines. Insider identified 19 key trials that could make or break the psychedelics industry's future. About 100 clinical trials are underway worldwide, examining the potential of psychedelics as treatments for health conditions, including post-traumatic stress disorder, severe depression, and anorexia. Phase III trials test the compounds in larger numbers of people with the condition. Companies use information from their Phase II studies to design Phase III trials and persuade the regulator to OK the design.
0 next >>
Total: 7